Health Care: Drugs

Immunogen Inc. (IMGN: NASDAQ)

$14.21 n/a | n/a%
04/16/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 14.21
52 Week High 20.25
52 Week Low 11.78
Avg. Daily Vol. (Mil) 0.87
Beta (3 year) 1.79
Share Related Items
Mkt Cap (Mil) 1,217.41
Shares Out (Mil) 85.67
Float (Mil) 59.62
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 10.40
Current Ratio 10.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 16.00
Price/Book 9.36
Price/Cash Flow -47.70
Per Share Data
Earnings -0.36
Sales 0.89
Book Value 1.52
Cash Flow -0.30
Business Summary
Immunogen, Inc. is focused on the antibody-based anticancer therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies and small molecule cytotoxic or cell-killing, agents.
General Information
830 Winter Street
Waltham, MA 02451
www.immunogen.com
Industry : Drugs
Sector: Health Care
Employees: 280
CEO: Mr. Daniel M. Junius
Short Interest
Current Month (Mil) 8.61
Previous Month (Mil) 8.83
Short Interest Ratio (Days) 11.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -15.10
Return on Investments -23.60
Profitability
Gross Margin n.a.
EBIT Margin -47.00
Profit Margin -40.30

Portfolios with IMGN

Latest IMGN Headlines from TheStreet

More Financial News for IMGN

Press Releases for IMGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter